TY - JOUR
T1 - Age-related Purkinje cell death is steroid dependent
T2 - ROR alpha haplo-insufficiency impairs plasma and cerebellar steroids and Purkinje cell survival
AU - Janmaat, Sonja
AU - Akwa, Yvette
AU - Doulazmi, Mohamed
AU - Bakouche, Joelle
AU - Gautheron, Vanessa
AU - Liere, Philippe
AU - Eychenne, Bernard
AU - Pianos, Antoine
AU - Luiten, Paul
AU - Groothuis, Ton
AU - Baulieu, Etienne-Emile
AU - Mariani, Jean
AU - Sherrard, Rachel M.
AU - Frederic, Florence
PY - 2011/12
Y1 - 2011/12
N2 - A major problem of ageing is progressive impairment of neuronal function and ultimately cell death. Since sex steroids are neuroprotective, their decrease with age may underlie age-related neuronal degeneration. To test this, we examined Purkinje cell numbers, plasma sex steroids and cerebellar neurosteroid concentrations during normal ageing (wild-type mice, WT), in our model of precocious ageing (Rora (+/sg) , heterozygous staggerer mice in which expression of the neuroprotective factor ROR alpha is disrupted) and after long-term hormone insufficiency (WT post-gonadectomy). During normal ageing (WT), circulating sex steroids declined prior to or in parallel with Purkinje cell loss, which began at 18 months of age. Although Purkinje cell death was advanced in WT long-term steroid deficiency, this premature neuronal loss did not begin until 9 months, indicating that vulnerability to sex steroid deficiency is a phenomenon of ageing Purkinje neurons. In precocious ageing (Rora (+/sg) ), circulating sex steroids decreased prematurely, in conjunction with marked Purkinje cell death from 9 months. Although Rora (+/sg) Purkinje cells are vulnerable through their ROR alpha haplo-insufficiency, it is only as they age (after 9 months) that sex steroid failure becomes critical. Finally, cerebellar neurosteroids did not decrease with age in either genotype or gender; but were profoundly reduced by 3 months in male Rora (+/sg) cerebella, which may contribute to the fragility of their Purkinje neurons. These data suggest that ageing Purkinje cells are maintained by circulating sex steroids, rather than local neurosteroids, and that in Rora (+/sg) their age-related death is advanced by premature sex steroid loss induced by ROR alpha haplo-insufficiency.
AB - A major problem of ageing is progressive impairment of neuronal function and ultimately cell death. Since sex steroids are neuroprotective, their decrease with age may underlie age-related neuronal degeneration. To test this, we examined Purkinje cell numbers, plasma sex steroids and cerebellar neurosteroid concentrations during normal ageing (wild-type mice, WT), in our model of precocious ageing (Rora (+/sg) , heterozygous staggerer mice in which expression of the neuroprotective factor ROR alpha is disrupted) and after long-term hormone insufficiency (WT post-gonadectomy). During normal ageing (WT), circulating sex steroids declined prior to or in parallel with Purkinje cell loss, which began at 18 months of age. Although Purkinje cell death was advanced in WT long-term steroid deficiency, this premature neuronal loss did not begin until 9 months, indicating that vulnerability to sex steroid deficiency is a phenomenon of ageing Purkinje neurons. In precocious ageing (Rora (+/sg) ), circulating sex steroids decreased prematurely, in conjunction with marked Purkinje cell death from 9 months. Although Rora (+/sg) Purkinje cells are vulnerable through their ROR alpha haplo-insufficiency, it is only as they age (after 9 months) that sex steroid failure becomes critical. Finally, cerebellar neurosteroids did not decrease with age in either genotype or gender; but were profoundly reduced by 3 months in male Rora (+/sg) cerebella, which may contribute to the fragility of their Purkinje neurons. These data suggest that ageing Purkinje cells are maintained by circulating sex steroids, rather than local neurosteroids, and that in Rora (+/sg) their age-related death is advanced by premature sex steroid loss induced by ROR alpha haplo-insufficiency.
KW - Ageing
KW - ROR alpha
KW - Cerebellum
KW - Purkinje cells
KW - Sex steroid hormones
KW - Neurosteroids
KW - ORPHAN RECEPTOR-ALPHA
KW - NERVE GROWTH-FACTOR
KW - NEUROTROPHIC FACTOR
KW - ALZHEIMERS-DISEASE
KW - SEX STEROIDS
KW - PROGESTERONE NEUROPROTECTION
KW - MULTIPLE-SCLEROSIS
KW - NUCLEAR RECEPTORS
KW - DENDRITIC GROWTH
KW - GENE-EXPRESSION
U2 - 10.1007/s11357-010-9203-3
DO - 10.1007/s11357-010-9203-3
M3 - Article
SN - 0161-9152
VL - 33
SP - 565
EP - 578
JO - AGE
JF - AGE
IS - 4
ER -